Dutogliptin is an investigational drug.
There have been 10 clinical trials for Dutogliptin.
The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2009.
The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and Myocardial Ischemia. The leading clinical trial sponsors are Phenomix, Forest Laboratories, and Recardio, Inc.